(Q34904702)

5 August 2017

title

Immunological responsiveness of tuberculosis patients receiving rifampin (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

Ruben FL

1

1 reference

5 August 2017

Winkelstein A

series ordinal

2

1 reference

5 August 2017

Fotiadis IG

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 April 1974

1 reference

Antimicrobial Agents and Chemotherapy

5 August 2017

published in

1 reference

5 August 2017

volume

5

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

383-387

1 reference

Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

Mechanisms of immunosuppression: effect of cyclophosphamide on responses to influenza immunization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

Effect of rifampin on cutaneous hypersensitivity to purified protein derivative in humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

Light chain proteinuria and humoral immunoincompetence in tuberculous patients treated with rifampin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

Effect of Rifampin on the Immune Response in Guinea Pigs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

Immunosuppressive effect of rifampicin.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

Rifampicin: an immunosuppressant?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

In vivo and in vitro Suppression of Humoral and Cellular Immunological Response by Rifampicin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

A New Subunit Influenza Vaccine: Acceptability Compared with Standard Vaccines and Effect of Dose on Antigenicity

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428979

Conditions for Immunosuppression by Rifampicin

26 October 2018

1 reference

12 December 2020

Rifampin in the Treatment of Drug-ResistantMycobacterium tuberculosisInfections

1 reference

12 December 2020

Studies on the antiviral effect of rifampicin in volunteers

1 reference

12 December 2020

Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial

1 reference

12 December 2020

Rifampicin: an immunosuppressant?

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.5.4.383

1 reference

5 August 2017

1 reference

5 August 2017

1 reference